                         SEQUENCE LISTING

<110>  OREGON HEALTH & SCIENCE UNIVERSITY
 
<120>  HEPATITIS B VIRUS-SPECIFIC T CELL RESPONSES

<130>  4153.011PC01

<150>  62/858,764
<151>  2019-06-07

<160>  18    

<170>  PatentIn version 3.5

<210>  1
<211>  35
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  left reverse primer

<400>  1
catcgagcta gcaccatgga gaacatcaca tcagg                                  35


<210>  2
<211>  35
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  right forward primer

<400>  2
gtgttgatag gataggggaa tgtataccca aagac                                  35


<210>  3
<211>  35
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  right reverse primer

<400>  3
gtctttgggt atacattccc ctatcctatc aacac                                  35


<210>  4
<211>  67
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  left forward primer

<400>  4
ggaatcgtcg actcaagcgt aatctggaac atcgtatggg taaagattga cgataaggga       60

gaggcag                                                                 67


<210>  5
<211>  42
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward primer

<400>  5
gtggtaccct cgaggattgg ggaccctgcg ctgaacatgg ag                          42


<210>  6
<211>  40
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse primer

<400>  6
tcagtcgacc taagcgtaat ctggaacatc gtatgggtac                             40


<210>  7
<211>  37
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward primer

<400>  7
ctgctagcat ggacattgac ccttataaag aatttgg                                37


<210>  8
<211>  32
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse primer

<400>  8
ctaggtacca cattgagatt cccgagattg ag                                     32


<210>  9
<211>  75
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Rh110 S/PolN forward

<400>  9
gatcacgtca ttgacaccgg cctcccacca gctctcacat tctccgcatc accatggaga       60

acatcacatc aggat                                                        75


<210>  10
<211>  79
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Rh110 S/PolN reverse

<400>  10
caaaatatta ttacatggta cgcaatttat tgtctatttt cgttatttgt ttattcaagc       60

gtaatctgga acatcgtat                                                    79


<210>  11
<211>  78
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Rh110 Core/PolC forward

<400>  11
gatcacgtca ttgacaccgg cctcccacca gctctcacat tctccgcatc accatggaca       60

ttgaccctta taaagaat                                                     78


<210>  12
<211>  79
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Rh110 Core/PolC reverse

<400>  12
caaaatatta ttacatggta cgcaatttat tgtctatttt cgttatttgt ttatctaagc       60

gtaatctgga acatcgtat                                                    79


<210>  13
<211>  55
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward primer

<400>  13
ctgctagcat ggattacaag gatgacaagg acatcgaccc ttataaagaa tttgg            55


<210>  14
<211>  32
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse primer

<400>  14
ctagtcgaca cattgagatt cccgagattg ag                                     32


<210>  15
<211>  84
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward primer

<400>  15
gggaaatcac gtcatcaggc tgggtagtca acatgggcat acgaaacttg cccgaataga       60

tgctctcact taacggctga catg                                              84


<210>  16
<211>  84
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse primer

<400>  16
ccagaatgtg ctctactttt tggccagcgg gttggatgat ttcgcgcgtc atggactgct       60

tcactgtagc ttagtacgtt aaac                                              84


<210>  17
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  antigen

<400>  17

Pro Ser Val Arg Asp Leu Leu Asp Thr Ala Ser Ala Leu Tyr Arg 
1               5                   10                  15  


<210>  18
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  antigen

<400>  18

Thr Ala Leu Arg Gln Ala Ile Leu Cys Trp Gly Glu Leu Met Thr 
1               5                   10                  15  


